drugset / Trial / NCT01652586

Sedation Regimen in Patients Undergoing Cardiac Electrophysiology Study and Ablation : a Comparison Between Dexmedetomidine-remifentanil and Midazolam-remifentanil Combinations

NCT01652586 ↗

Completed 90 enrolled Yonsei University
RandomizedParallel-groupDouble-blindTreatment

Summary

Cardiac ablation is an invasive procedure requiring anesthetic support for immobility and analgesia. Benzodiazepines and opioids are the most commonly used agents, while they are associated with respiratory depression and hypotension. The aim of this study was to compare the effect of remifentanil and dexmedetomidine, which exerts sedative and analgesic effect without serious respiratory depression, with conventional midazolam/remifentanil combination on sedative and analgesic levels in patients undergoing endocardial ablation.

Timeline

Start
2011-04
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg Intravenous
Comparator Midazolam Small molecule 1 mg —
Comparator Midazolam Small molecule 2 mg —
Comparator Remifentanil Small molecule 3.6 ug/kg —
Comparator Remifentanil Small molecule 7.2 ug/kg —